INDANIO BIOSCIENCE

indanio-bioscience-logo

InDanio Bioscience Inc., is a privately-held in vivo drug discovery company dedicated to developing New Chemical Entities (NCEs) targeting the pharmaceutically-important Nuclear Receptor (NR) protein families. Their proprietary, Ligand Trap system, which includes 48 transgenic zebrafish lines, each singularly expressing one of the 48 human Nuclear Receptors, allows simultaneous assessment of drug delivery, stability, specificity, tissue-selectivity and toxicity. Selective, highest-value target lines are being used to identify, extract and characterize new hormonal regulators, as well as to identify new tissue-selective drugs, co-factors and mechanisms of action for each Nuclear Receptor.

#People #Financial #Website #More

INDANIO BIOSCIENCE

Industry:
Biotechnology Pharmaceutical

Founded:
2008-01-01

Address:
Toronto, Ontario, Canada

Country:
Canada

Website Url:
http://www.indanio.com

Total Employee:
1+

Status:
Active

Contact:
416-978-5531

Email Addresses:
[email protected]

Total Funding:
590 K USD

Technology used in webpage:
Alibaba AliDNS 51.la


Current Employees Featured

not_available_image

Henry Krause
Henry Krause Founder @ InDanio Bioscience
Founder

Founder


not_available_image

Henry Krause

Investors List

cqdm_image

CQDM

CQDM investment in Grant - InDanio Bioscience

ontario-centres-of-excellence_image

Ontario Centres of Excellence

Ontario Centres of Excellence investment in Grant - InDanio Bioscience

ontario-genomics_image

Ontario Genomics

Ontario Genomics investment in Grant - InDanio Bioscience

Official Site Inspections

http://www.indanio.com

  • Host name: 23.227.38.67
  • IP address: 23.227.38.67
  • Location: Canada
  • Latitude: 43.6319
  • Longitude: -79.3716
  • Timezone: America/Toronto

Loading ...

More informations about "InDanio Bioscience" on Search Engine